17/05/2024

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

17/05/2024

May 17, 2024, 13:11 | Insight
Yelak Biru: Kite and Arcellx have announced plans to commence a Phase III clinical trial for myeloma
Yelak Biru, President and CEO of the International Myeloma Foundation, shared on X: . "We…
May 17, 2024, 13:09 | Blog
Bursting the Cervical Cancer Bubble with Dr. Yin Ling Woo - ROSE Foundation
Yin Ling Woo, Professor of Obstetrics and Gynaecology at University of Malaya shared a post…
May 17, 2024, 12:54 | Insight
Piotr Wysocki: Anti-HER2 treatment in patients with advanced biliary cancer
Piotr Wysocki recently posted on LinkedIn: "The Targeted Agent and Profiling Utilization Registry (TAPUR) Study is…
May 17, 2024, 12:21 | Blog
CCR researchers reported that the Tox2 gene is critical for the function of certain gut cells - NCI Center for Cancer Research
NCI Center for Cancer Research posted on LinkedIn: "NEW FINDINGS: CCR researchers reported that the…
May 17, 2024, 12:10 | Societies
Federica Miglietta: Truly stimulating discussion by P.A. Fasching in the first Mini Oral Session at ESMOBreast24
Federica Miglietta, Oncology Fellow at University of Padova, shared a post by Evandro de Azambuja,…
May 17, 2024, 12:10 | Blog
Jacob Adashek: A labor of love I created for NCI PDQ - Agnostic Cancer Therapies Treatment Summary Tissue
Jacob Adashek, Medical oncology fellow at the Sidney Kimmel Comprehensive Cancer Center at the Johns…
May 17, 2024, 11:41 | Insight
Sara Tolaney: Helpful discussion by Cristina Saura on how to think about adjuvant therapies in patients with gBRCAm
Sara Tolaney shared a post on X: “Very helpful discussion by Cristina Saura on how…
May 17, 2024, 11:25 | Insight
Stefan Michiels: Discussing important clinical trial design challenges in breast cancer!
Stefan Michiels, Head Oncostat Team at INSERM, shared a post by Marleen Kok, Associate Professor…
May 17, 2024, 11:18 | Drugs
Agenus has been granted a Type B End-of-Phase 2 meeting from the U.S. FDA
Agenus shared on LinkedIn: “Today we announced that Agenus has been granted a Type B…
May 17, 2024, 11:05 | Blog
David D. W. Lee: Honoured to represent Malaysia in the ESMO Pan-Asian Guidelines Adaptation for oncogene-addicted mNSCLC
David D. W. Lee, Consultant Clinical Oncologist at University of Malaya Medical Centre, made the…
All: 83 Posts: 51 - 60